Shanghai Haixin Group Co

Shanghai Haixin Group Co Equity

The The Equity of Shanghai Haixin Group Co (600851.SS) as of Oct 23, 2026 is 4.72 B CNY. In the previous year, The Equity was 4.33 B CNY — a change of 8.84% (higher).

Equity

4.72 BCNY

YoY

8.84%

Last updated:

In 2025, Shanghai Haixin Group Co's equity was 4.72 B CNY, a 8.84% increase from the 4.33 B CNY equity in the previous year.

The Shanghai Haixin Group Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
3.42 B CNY
Jan 1, 2019
3.85 B CNY
Jan 1, 2020
4.19 B CNY
Jan 1, 2021
4.13 B CNY
Jan 1, 2022
3.84 B CNY
Jan 1, 2023
3.97 B CNY
Jan 1, 2024
4.33 B CNY
Jan 1, 2025
4.72 B CNY
The Shanghai Haixin Group Co Equity history
YEAREquityYoY
4.72 BCNY+8.84%
4.33 BCNY+9.31%
3.97 BCNY+3.16%
3.84 BCNY-6.90%
4.13 BCNY-1.45%
4.19 BCNY+8.84%
3.85 BCNY+12.51%
3.42 BCNY-9.55%
3.78 BCNY-8.81%
4.15 BCNY-9.34%
4.57 BCNY-14.13%
5.33 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Haixin Group Co Stock analysis

What does Shanghai Haixin Group Co do? Shanghai Haixin Group Co., Ltd. generates revenue through its Textile segment, which produces and sells plush fabrics and clothing, and its Pharmaceutical segment, which manufactures and sells pharmaceutical products. The company also earns income from financial investment business and industrial plant rental management, operating across domestic and overseas markets. Its primary customers include businesses purchasing textiles for clothing production and pharmaceutical buyers seeking medical products, while the financial investment segment attracts institutional investors. The firm's domestic market focus complements its overseas sales channels for both textile and pharmaceutical goods. The Textile segment's plush fabrics and clothing are sold to manufacturers and retailers, while the Pharmaceutical segment's products target healthcare providers and distributors. Financial investments provide passive income streams, and industrial plant rentals contribute to operational revenue. The company's dual-segment approach ensures diversified income sources from both product manufacturing and asset management. Shanghai Haixin's business model relies on the consistent demand for plush fabrics in the apparel industry and pharmaceutical products in healthcare. The financial investment segment leverages capital to generate returns, and industrial plant rentals utilize underused facilities for additional revenue. These segments collectively serve domestic and international clients without relying on external partnerships or third-party services. Shanghai Haixin Group Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Shanghai Haixin Group Co's Equity

Shanghai Haixin Group Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Shanghai Haixin Group Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Shanghai Haixin Group Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Shanghai Haixin Group Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Shanghai Haixin Group Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Shanghai Haixin Group Co stock

The Equity of Shanghai Haixin Group Co is 4.72 B CNY in 2025.

The Equity of Shanghai Haixin Group Co changed from 4.33 B CNY to 4.72 B CNY, representing a 8.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Shanghai Haixin Group Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Shanghai Haixin Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Shanghai Haixin Group Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Shanghai Haixin Group Co